Vitalhub (TSE:VHI – Get Free Report) had its price objective decreased by analysts at ATB Cormark Capital Markets from C$12.00 to C$10.25 in a research report issued on Monday, BayStreet reports. The firm presently has an “outperform” rating on the stock. ATB Cormark Capital Markets‘s target price points to a potential upside of 57.21% from the company’s current price.
Separately, Canaccord Genuity Group set a C$15.00 target price on shares of Vitalhub and gave the stock a “buy” rating in a research report on Friday, August 28th. Nine analysts have rated the stock with a Buy rating. According to MarketBeat.com, Vitalhub presently has a consensus rating of “Buy” and an average target price of C$10.86.
Read Our Latest Research Report on Vitalhub
Vitalhub Stock Performance
Shares of Vitalhub stock traded down C$0.48 on Monday, reaching C$6.52. The stock had a trading volume of 481,442 shares, compared to its average volume of 297,780. The business’s 50-day moving average price is C$7.56 and its two-hundred day moving average price is C$7.58. Vitalhub has a fifty-two week low of C$6.46 and a fifty-two week high of C$9.77. The stock has a market cap of C$412.97 million, a P/E ratio of 54.33, a price-to-earnings-growth ratio of 1.18 and a beta of 1.37.
Vitalhub (TSE:VHI – Get Free Report) last posted its quarterly earnings data on Thursday, November 12th. The company reported C$0.04 earnings per share (EPS) for the quarter. Vitalhub had a net margin of 8.63% and a return on equity of 4.03%. The business had revenue of C$31.91 million during the quarter. As a group, equities analysts forecast that Vitalhub will post 0.23 earnings per share for the current fiscal year.
Vitalhub Company Profile
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
Further Reading
- Five stocks we like better than Vitalhub
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
